(NASDAQ: BTMD) Biote's forecast annual revenue growth rate of 3.09% is not forecast to beat the US Medical Care Facilities industry's average forecast revenue growth rate of 4.01%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 25.62%.
Biote's revenue in 2025 is $195,645,000.On average, 7 Wall Street analysts forecast BTMD's revenue for 2025 to be $8,926,587,539, with the lowest BTMD revenue forecast at $8,506,947,969, and the highest BTMD revenue forecast at $9,237,550,049. On average, 7 Wall Street analysts forecast BTMD's revenue for 2026 to be $9,176,818,751, with the lowest BTMD revenue forecast at $8,100,093,936, and the highest BTMD revenue forecast at $9,972,718,392.
In 2027, BTMD is forecast to generate $9,915,183,478 in revenue, with the lowest revenue forecast at $8,715,626,188 and the highest revenue forecast at $11,075,470,907.